v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating Activities:    
Net income (loss) attributable to common stockholders $ 408,680 $ 31,016
Adjustments to reconcile net income to net cash provided by (used in) operating activities    
Net realized and unrealized (gains) losses 264 441
Non-cash compensation expense 4,360 9,859
Amortization/accretion of premiums and discounts (2,252) (1,018)
Depreciation and amortization expense 1,083 1,083
Non-cash lease expense 1,397 1,441
Deferred provision (benefit) for income taxes (0) (5,741)
Amortization of deferred financing costs 0 0
Net income from discontinued operations [1] (417,645) (60,666)
Changes in operating assets and liabilities:    
(Increase) decrease in other assets 611 1,159
Increase (decrease) in other liabilities and lease obligations (11,962) (2,824)
Net cash provided by (used in) operating activities from continuing operations (15,464) (25,250)
Net cash provided by (used in) operating activities from discontinued operations (131,763) 148,616
Net cash provided by (used in) operating activities (147,227) 123,366
Investing Activities:    
Purchases of investments (878,289) (90,506)
Proceeds from sales and maturities of investments 183,105 61,344
Net cash provided by (used in) investing activities from continuing operations (695,184) (29,162)
Net cash provided by (used in) investing activities from discontinued operations 697,667 (93,729)
Net cash provided by (used in) investing activities 2,483 (122,891)
Financing Activities:    
Dividends paid (6,770) (6,788)
Non-controlling interest (redemptions) contributions (5) 0
Cash (paid) received in connection with vested or exercised stock awards (502) (6,587)
Payment of debt issuance costs (50) (2,285)
Proceeds from borrowings and mortgage notes payable 0 74,250
Principal paydowns of borrowings and mortgage notes payable (74,249) (563)
Repurchases of common stock and other changes in additional paid-in capital (17,092) 0
Net cash provided by (used in) financing activities from continuing operations (98,668) 58,027
Net cash provided by (used in) financing activities from discontinued operations 42,160 24
Net cash provided by (used in) financing activities (56,508) 58,051
Effect of exchange rate changes on cash 2,193 4,770
Net increase (decrease) in cash, cash equivalents and restricted cash (199,059) 63,296
Cash, cash equivalents and restricted cash – beginning of period 30,784 19,437
Cash, cash equivalents and restricted cash - beginning of period - held for sale 366,587 396,827
Cash, cash equivalents and restricted cash - end of period 198,312 [2] 479,560
Less: Reclassification of cash to held for sale 0 456,789
Cash, cash equivalents and restricted cash – end of period $ 198,312 $ 22,771
[1] See Note (3) Dispositions and Discontinued Operations for further details.
[2] The December 31, 2025 balance includes cash and cash equivalents associated with assets held for sale. Such amounts were included in assets held for sale on the Condensed Consolidated Balance Sheet as of December 31, 2025.